Tirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer

NCT00020696 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
NETWORK
Sponsor class

Conditions

Interventions

Sponsor

Gynecologic Oncology Group

Collaborators